NCT06531356View on ClinicalTrials.gov

Efficiency of Autologous Amniotic Fluid Injection in the Healing of Cesarean Section Scar in High-Risk Population

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

February 16, 2024

Primary Completion Date

May 16, 2024

Study Completion Date

May 20, 2024

Conditions
High Risk PregnancyHealing Surgical Wounds
Interventions
BIOLOGICAL

autologous amniotic fluid

10 cc of amniotic fluid aspirated after opening uterine incision in cesarean section, then Injected in edges of skin before closure

OTHER

No amniotic fluid injected in skin edges

conventional closure of skin

Trial Locations (1)

11562

kasr Al Aini, Faculty of Medicine, Cairo University, Cairo

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER

NCT06531356 - Efficiency of Autologous Amniotic Fluid Injection in the Healing of Cesarean Section Scar in High-Risk Population | Biotech Hunter | Biotech Hunter